文献速递乳腺癌放疗放疗物理与技术

乳腺癌放疗中分次内实时运动管理:2028次治疗分次的分析

Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions.
PubMed 文献 · Radiat Oncol · 2018-07-16

研究前瞻性评估104例乳腺癌术后放疗患者共2028次治疗分次中的分次内运动,使用Catalyst光学表面扫描仪实时连续测量。结果显示偏差向量最大幅度平均为1.93 mm±1.14 mm,各方向分次内运动均在5 mm以内,作者认为在该系列中分次内运动临床相关性似乎较小。

要点

  • 104例乳腺癌术后放疗患者2028次治疗分次中,偏差向量最大幅度平均1.93 mm±1.14 mm(95%CI 0.48-4.65 mm)。
  • 横向与纵向轴变化相似(0.18 mm±1.06 mm vs 0.17 mm±1.32 mm),垂直轴平均变化0.68 mm±1.53 mm。
  • 各方向分次内运动均在5 mm以内,作者认为在该系列中临床相关性似乎较小。

核心结论

  • 光学表面成像系统是乳腺癌放疗中实时运动管理的准确且简便工具。
  • 各方向分次内运动报告在5毫米以内。
  • 在该2028次治疗分次系列中,乳腺癌术后放疗的分次内运动似乎具有较小的临床相关性。

研究设计与样本

  • 前瞻性评估104例连续接受乳腺癌保乳术后或乳房切除术后放疗的患者,共2028次治疗分次。
  • 每次治疗分次使用Catalyst™光学表面扫描仪(C-RAD AB,瑞典)连续测量患者运动,并与每次分次开始时采集的参考扫描进行比较。
  • Catalyst系统通过发光二极管(LED)光的光学表面成像和电荷耦合器件(CCD)相机捕获的再投影工作,运动检测精度为0.5 mm。
  • 系统使用非刚体算法计算表面与等中心之间的距离,并利用光学三角测量原理进行三维表面重建。
  • 系统计算整个治疗分次期间的三维偏差和相对位置差异并进行统计分析。

主要发现

  • 总体而言,偏差向量最大幅度的平均变化为1.93 mm±1.14 mm(标准差),95%置信区间为0.48-4.65 mm。
  • 仅在束流开启期间,偏差向量最大幅度的中位变化为1.63 mm。
  • 横向轴平均变化为0.18 mm±1.06 mm,纵向轴为0.17 mm±1.32 mm,垂直轴为0.68 mm±1.53 mm。
  • 平均治疗分次时间为154±53秒(标准差),仅束流开启时间平均为55±16秒。
  • Friedman检验显示三个可能方向(横向、纵向和垂直)的分布差异显著(p<0.01),事后分析中三个方向中任意两个之间均无相似性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intra-fraction motion represents a crucial issue in the era of precise radiotherapy in several settings, including breast irradiation. To date, only few data exist on real-time measured intra-fraction motion in breast cancer patients. Continuous surface imaging using visible light offers the capability to monitor patient movements in three-dimensional space without any additional radiation exposure. The aim of the present study was to quantify the uncertainties of possible intra-fractional motion during breast radiotherapy. MATERIAL AND METHODS: One hundred and four consecutive patients that underwent postoperative radiotherapy following breast conserving surgery or mastectomy were prospectively evaluated during 2028 treatment sessions. During each treatment session the patients' motion was continuously measured using the Catalyst™ optical surface scanner (C-RAD AB, Sweden) and compared to a reference scan acquired at the beginning of each session. The Catalyst system works through an optical surface imaging with light emitting diode (LED) light and reprojection captured by a charge coupled device (CCD) camera, which provide target position control during treatment delivery with a motion detection accuracy of 0.5 mm. For 3D surface reconstruction, the system uses a non-rigid body algorithm to calculate the distance between the surface and the isocentre and using the principle of optical triangulation. Three-dimensional deviations and relative position differences during the whole treatment fraction were calculated by the system and analyzed statistically. RESULTS: Overall, the maximum magnitude of the deviation vector showed a mean change of 1.93 mm ± 1.14 mm (standard deviation [SD]) (95%-confidence interval: [0.48-4.65] mm) and a median change of 1.63 mm during dose application (beam-on time only). Along the lateral and longitudinal axis changes were quite similar (0.18 mm ± 1.06 mm vs. 0.17 mm ± 1.32 mm), on the vertical axis the mean change was 0.68 mm ± 1.53 mm. The mean treatment session time was 154 ± 53 (SD) seconds and the mean beam-on time only was 55 ± 16 s. According to Friedman's test differences in the distributions of the three possible directions (lateral, longitudinal and vertical) were significant (p < 0.01), in post-hoc analysis there were no similarities between any two of the three directions. CONCLUSION: The optical surface imaging system is an accurate and easy tool for real-time motion management in breast cancer radiotherapy. Intra-fraction motion was reported within five millimeters in all directions. Thus, intra-fraction motion in our series of 2028 treatment sessions seems to be of minor clinical relevance in postoperative radiotherapy of breast cancer.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Reitz D, Carl G, Schönecker S, et al. Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions. Radiat Oncol. 2018. PMID: 30012156. doi:10.1186/s13014-018-1072-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。